Complete response of bony metastatic bladder urothelial cancer to neoadjuvant chemotherapy and cystectomy

Fadi N. Joudi; Laila Dahmoush; David M. Spector; Badrinath R. Konety

doi:10.1016/j.urolonc.2005.12.002

Complete response of bony metastatic bladder urothelial cancer to neoadjuvant chemotherapy and cystectomy

Fadi N. Joudi, Laila Dahmoush, David M. Spector, Badrinath R. Konety

Urology

Research output: Contribution to journal › Article › peer-review

6 Scopus citations

Abstract

We report on a 38-year-old male diagnosed with biopsy-proven bladder urothelial carcinoma metastatic to the bone, who had a complete response to neoadjuvant chemotherapy consisting of carboplatin and gemcitabine. The final pathology of his radical cystoprostatectomy revealed no residual cancer. The patient continues to be without evidence of disease 2 years postoperatively. This case shows that neoadjuvant chemotherapy with nonstandard regimens can yield responses in patients with bone metastases.

Original language	English (US)
Pages (from-to)	403-406
Number of pages	4
Journal	Urologic Oncology: Seminars and Original Investigations
Volume	24
Issue number	5
DOIs	https://doi.org/10.1016/j.urolonc.2005.12.002
State	Published - Sep 2006

Keywords

Chemotherapy
Cystectomy
Metastasis
Survival
Urothelial carcinoma

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access

10.1016/j.urolonc.2005.12.002

OpenUrl availability

Full text

Cite this

@article{b0f53023ab6c49c3900c49709d8ebe18,

title = "Complete response of bony metastatic bladder urothelial cancer to neoadjuvant chemotherapy and cystectomy",

abstract = "We report on a 38-year-old male diagnosed with biopsy-proven bladder urothelial carcinoma metastatic to the bone, who had a complete response to neoadjuvant chemotherapy consisting of carboplatin and gemcitabine. The final pathology of his radical cystoprostatectomy revealed no residual cancer. The patient continues to be without evidence of disease 2 years postoperatively. This case shows that neoadjuvant chemotherapy with nonstandard regimens can yield responses in patients with bone metastases.",

keywords = "Chemotherapy, Cystectomy, Metastasis, Survival, Urothelial carcinoma",

author = "Joudi, {Fadi N.} and Laila Dahmoush and Spector, {David M.} and Konety, {Badrinath R.}",

year = "2006",

month = sep,

doi = "10.1016/j.urolonc.2005.12.002",

language = "English (US)",

volume = "24",

pages = "403--406",

journal = "Urologic Oncology: Seminars and Original Investigations",

issn = "1078-1439",

publisher = "Elsevier Inc.",

number = "5",

}

TY - JOUR

T1 - Complete response of bony metastatic bladder urothelial cancer to neoadjuvant chemotherapy and cystectomy

AU - Joudi, Fadi N.

AU - Dahmoush, Laila

AU - Spector, David M.

AU - Konety, Badrinath R.

PY - 2006/9

Y1 - 2006/9

N2 - We report on a 38-year-old male diagnosed with biopsy-proven bladder urothelial carcinoma metastatic to the bone, who had a complete response to neoadjuvant chemotherapy consisting of carboplatin and gemcitabine. The final pathology of his radical cystoprostatectomy revealed no residual cancer. The patient continues to be without evidence of disease 2 years postoperatively. This case shows that neoadjuvant chemotherapy with nonstandard regimens can yield responses in patients with bone metastases.

AB - We report on a 38-year-old male diagnosed with biopsy-proven bladder urothelial carcinoma metastatic to the bone, who had a complete response to neoadjuvant chemotherapy consisting of carboplatin and gemcitabine. The final pathology of his radical cystoprostatectomy revealed no residual cancer. The patient continues to be without evidence of disease 2 years postoperatively. This case shows that neoadjuvant chemotherapy with nonstandard regimens can yield responses in patients with bone metastases.

KW - Chemotherapy

KW - Cystectomy

KW - Metastasis

KW - Survival

KW - Urothelial carcinoma

UR - http://www.scopus.com/inward/record.url?scp=33748160966&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33748160966&partnerID=8YFLogxK

U2 - 10.1016/j.urolonc.2005.12.002

DO - 10.1016/j.urolonc.2005.12.002

M3 - Article

C2 - 16962489

AN - SCOPUS:33748160966

SN - 1078-1439

VL - 24

SP - 403

EP - 406

JO - Urologic Oncology: Seminars and Original Investigations

JF - Urologic Oncology: Seminars and Original Investigations

IS - 5

ER -

Complete response of bony metastatic bladder urothelial cancer to neoadjuvant chemotherapy and cystectomy

Abstract

Keywords

UN SDGs

Access

OpenUrl availability

Other files and links

Fingerprint

Cite this